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Abstract: Uridine diphosphate-glucose dehydrogenase (UGD) is an enzyme that produces uridine
diphosphate-glucuronic acid (UDP-GlcA), which is an intermediate in glycosaminoglycans (GAGs)
production pathways. GAGs are generally extracted from animal tissues. Efforts to produce GAGs in
a safer way have been conducted by constructing artificial biosynthetic pathways in heterologous
microbial hosts. This work characterizes novel enzymes with potential for UDP-GlcA biotechnological
production. The UGD enzymes from Zymomonas mobilis (ZmUGD) and from Lactobacillus johnsonii
(LbjUGD) were expressed in Escherichia coli. These two enzymes and an additional eukaryotic one
from Capra hircus (ChUGD) were also expressed in Saccharomyces cerevisiae strains. The three enzymes
herein studied represent different UGD phylogenetic groups. The UGD activity was evaluated
through UDP-GlcA quantification in vivo and after in vitro reactions. Engineered E. coli strains
expressing ZmUGD and LbjUGD were able to produce in vivo 28.4 µM and 14.9 µM UDP-GlcA,
respectively. Using S. cerevisiae as the expression host, the highest in vivo UDP-GlcA production was
obtained for the strain CEN.PK2-1C expressing ZmUGD (17.9 µM) or ChUGD (14.6 µM). Regarding
the in vitro assays, under the optimal conditions, E. coli cell extract containing LbjUGD was able to
produce about 1800 µM, while ZmUGD produced 407 µM UDP-GlcA, after 1 h of reaction. Using
engineered yeasts, the in vitro production of UDP-GlcA reached a maximum of 533 µM using
S. cerevisiae CEN.PK2-1C_pSP-GM_LbjUGD cell extract. The UGD enzymes were active in both
prokaryotic and eukaryotic hosts, therefore the genes and expression chassis herein used can be
valuable alternatives for further industrial applications.
Keywords: UDP-glucose dehydrogenase; UDP-glucuronic acid; glycosaminoglycans biosynthesis;
heterologous production; Escherichia coli; Saccharomyces cerevisiae
1. Introduction
Uridine diphosphate-glucose dehydrogenase (UDP-glucose dehydrogenase, UGD,
EC 1.1.1.22) is an oxidoreductase that catalyzes the production of UDP-glucuronic acid
(UDP-GlcA) from UDP-glucose (UDP-Glc). UDP-GlcA is a compound with diverse ap-
plications whose major biotechnological use is as a precursor for glycosaminoglycans
(GAGs) production [1].
Glycosaminoglycans (GAGs) are a class of natural long linear polysaccharides that
include hyaluronic acid, heparan sulfate, and chondroitin sulfate which have medical,
veterinary, pharmaceutical, and cosmetic applications. Nevertheless, except for hyaluronic
acid that is produced by microbial fermentation, GAGs are mainly extracted from ani-
mal sources using laborious methods and hazardous reagents, generating products with
heterogeneous compositions, raising concerns of adulteration and risks of prion contam-
ination, which ultimately limits their large-scale production [2]. Additionally, religious,
and ethical issues alongside with vegetarianism trends are key factors driving the search
for non-animal sources of GAGs. An eco-friendly and controllable alternative consists
of the metabolic engineering of microbial cell factories to produce GAGs from simple
carbon sources [3–5].
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Several pathogenic microorganisms have been reported as GAG-like polysaccharides
producers through well-known pathways (Figure 1). For example, group A and C strep-
tococci and Pasteurella multocida type A produce hyaluronic acid [6,7]; Escherichia coli K5,
P. multocida type D and Avibacterium paragallinarum genotype II can synthesize a capsular
polysaccharide, heparosan, structurally analogous to unsulfated heparin [8–10]; E. coli
O5:K4:H4 synthesizes a capsular polysaccharide composed by unsulfated fructosylated
chondroitin [8]; and P. multocida type F and A. paragallinarium genotype I produce un-
sulfated chondroitin [9,10]. However, the biotechnological production of GAGs at an
industrial-scale, and especially of sulfated GAGs, is limited, due to low yields and safety
issues related to the cultivation of pathogenic microorganisms [11]. Therefore, in the past
few years research efforts have been focused on the improvement of the production process,
as well as on the design of better heterologous hosts to produce GAGs. Recent advances
in the microbial production of GAGs using non-pathogenic hosts (mostly prokaryotic
organisms) have been reported [12–19].
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Figure 1. Production of uridine diphosphate (UDP)-glucuronic acid in Escherichia coli and its possible use in the biosyn-
thesis of microbial chondroitin, hyaluronic acid, or heparosan. Depending on the microbial host, the heterologous expres-
sion of the enzymes shown in orange might be required for glycosaminoglycans production. Enzyme abbreviations: GalU, 
uridine-triphosphate:glucose-1-phosphate uridylyltransferase; GlmM, phosphoglucosamine mutase; GlmS, glucosamine-
6-phosphate synthase; GlmU, glucosamine-1-phosphate N-acetyltransferase/N-acetylglucosamine-1-phosphate uridyl-
transferase; HasA, hyaluronan synthase; KfiA, β-1,3-glucuronyltransferase; KfiC, α-1,4-N-acetylglucosaminyltransferase; 
KfoC, chondroitin synthase; Pgi, glucose-6-phosphate isomerase; Pgm, phosphoglucomutase; Uae, UDP-N-acetylglucosa-
mine 4-epimerase; UGD, UDP-glucose 6-dehydrogenase. 
The heterologous pathway design should take into account every enzymatic step to 
maximize GAGs yields. The step catalyzed by UGD was previously considered to be the 
limiting factor of GAG biosynthesis in homologous and heterologous organisms 
[13,16,20]. Since the first discovered UGD [21], genes encoding UGD have been identified 
in almost all organisms, from which alternative genes can be extracted for further evalu-
Figure 1. Production of uridine diphosphate (UDP)-glucuronic acid in Escherichia coli and its possible use in the biosynthesis
of microbial chondroitin, hyaluronic acid, or heparosan. Depending on the microbial host, the heterologous expression
of the enzymes shown in orange might be required for glycosaminoglycans production. Enzyme abbreviations: GalU,
uridine-triphosphate:glucose-1-phosphate uridylyltransferase; GlmM, phosphoglucosamine mutase; GlmS, glucosamine-6-
phosphate synthase; GlmU, glucosamine-1-phosphate N-acetyltransferase/N-acetylglucosamine-1-phosphate uridyltrans-
ferase; HasA, hyaluronan synthase; KfiA, β-1,3-glucuronyltransferase; KfiC, α-1,4-N-acetylglucosaminyltransferase; KfoC,
chondroit n synthase; Pgi, glucose-6-phosp ate isomerase; Pgm, phosphoglucomutase; Uae, UDP-N-acetylglucosamine
4-epimerase; UGD, UDP-glucose 6-dehydrogenase.
The heterologous pathway design should take into account every enzymatic step to
maximize GAGs yields. The step catalyzed by UGD was previously considered to be the
limiting factor of GAG biosynthesis in homologous and heterologous organisms [13,16,20].
Since the first discovered UGD [21], genes encoding UGD have been identified in almost
all organisms, from which alternative genes can be extracted for further evaluation as
biocatalytic producers of UDP-GlcA. However, although UGD genes are widespread across
nature, few UGD have been biochemically characterized or evaluated in heterologous
hosts. The overexpression of UGD enzyme in a heterologous host is needed even in hosts
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containing the gene as it is often over-regulated limiting its expression [22]. Additionally,
no eukaryotic heterologous host has yet been evaluated for the production of some GAGs.
Eukaryotic hosts can be a favorable alternative for eukaryotic gene expression offering an
interesting platform for complex integrated production and sulfation systems.
In this study, the expression of three novel genes encoding UGD was evaluated to
expand the knowledge of potential candidates for the construction of GAGs biosynthetic
pathways. Two prokaryotic UGDs from Zymomonas mobilis (ZmUGD) and Lactobacillus
johnsonii (LbjUGD) were expressed in E. coli BL21 (DE3). In addition, a eukaryotic system
was also used for heterologous expression of these UGD enzymes to assess if this chassis
could be a proper platform for GAGs production. Saccharomyces cerevisiae CEN.PK2-1C and
S. cerevisiae BY4741 were used to express ZmUGD and LbjUGD and an additional UGD from
Capra hircus (ChUGD) that has never been evaluated. These enzymes are representatives of
each of the three evolutionary groups identified by an evolutionary analysis, namely from
group I and II of prokaryotic UGD and from the eukaryotic group. The expressed UGD
enzymes were characterized for the first time in a prokaryotic and eukaryotic host through
in vivo and in vitro reactions by quantification of UDP-GlcA production. These enzymes
were found to have a high catalytic efficiency and to be suitable for use in the construction
of biosynthetic pathways for GAGs production. In addition, S. cerevisiae was demonstrated
to be a suitable alternative platform for UDP-GlcA production.
2. Materials and Methods
2.1. Multiple Sequence Alignment and Evolutionary Relationships
The evolutionary relationship of the three UGD enzymes explored in this work,
ChUGD, ZmUGD, and LbjUGD (GenBank sequences XP_013820045.1 WP_012817132.1,
ABM21411.1, respectively), was accessed. Clustal Omega (1.2.4) tool of European Molecular
Biology Laboratory—European Bioinformatics Institute (EMBL-EBI, https://www.ebi.ac.
uk/Tools/msa/clustalo/, accessed on 3 November 2021) was used to perform a multiple
amino acid sequences alignment of the three enzymes and their domains were predicted us-
ing the HMMER web service (EMBL-EBI, https://www.ebi.ac.uk/Tools/hmmer/search/
phmmer, accessed on 3 November 2021). Using ZmUGD amino acid sequence as query,
a sequence similarity search was performed using BLASTp tool at National Center for
Biotechnology Information (NCBI, https://blast.ncbi.nlm.nih.gov/, accessed on 3 Novem-
ber 2021), against the reviewed proteins in the SwissProt/UniProt database. The identified
homologous protein sequences and 5 additional relevant protein sequences from known
GAG producers (a total of 63 representative enzymes) were analyzed through multiple
sequence alignment (ClustalW algorithm) and evolutionary analysis in MEGA-X [23]. The
phylogenetic tree was constructed in MEGA-X using the Neighbor-Joining method [24].
The Poisson correction method was used to compute evolutionary distances [25] which are
in the units of the number of amino acid substitutions per site. All ambiguous positions
were removed for each sequence pair (pairwise deletion option).
2.2. Strains and Plasmids
The strains and plasmids used in this study are listed in Table 1. Z. mobilis ATCC 29191
and L. johnsonii ATCC 11506 were obtained from the American Type Culture Collection
(ATCC, Manassas, VA, USA) and used as genomic DNA (gDNA) source for amplification
of UGD genes. E. coli NZY5α (NZYTech, Lisbon, Portugal) was used for cloning procedures
and vector propagation. E. coli BL21 (DE3) (NZYTech) was used as expression host of
ZmUGD or LbjUGD genes using pRSFDuet-1 (Novagen, Madison, WI, USA) as the expres-
sion vector. S. cerevisiae CEN.PK2-1C and S. cerevisiae BY4741 strains were obtained from
Euroscarf (Oberursel, Germany) and used for UGD expression. In this case, two different
shuttle vectors were also tested, namely pSP-GM1 (PGK1 promoter, Addgene, Watertown,
MA, USA) and p426GPD (ATCC).
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Table 1. Strains and plasmids used in this study.
Strains Relevant Genotype Source
Zymomonas mobilis subsp. mobilis ATCC 29191 Wild type ATCC 29191
Lactobacillus johnsonii ATCC 11506 Wild type ATCC 11506
Escherichia coli NZY5α fhuA2 ∆(argF
−lacZ)U169 phoA glnV44Φ80 ∆(lacZ)M15
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 NZYTech (MB00401)
E. coli BL21 (DE3) F
− ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 *lacI lacUV5-T7
gene 1 ind1 sam7 nin5]) NZYTech (MB006)
Saccharomyces cerevisiae CEN.PK2-1C MATa ura3-52 his3∆1 leu2-3, 112 trp1-289 MAL2-8c SUC2 Euroscarf 30000A [26]
S. cerevisiae BY4741 MATa his3∆1 leu2∆0 met15∆0 ura3∆0 Euroscarf Y00000 [27]
Plasmids Description Source
pGEM®-T Easy ColE1/pMB1/pBR322/pUC ori, lacZ, AmpR Promega
pRSFDuet-1 RSF1030 ori, lacI, double PT7lac, KanR Novagen
pGEM_LbjUGD pGEM®-T Easy harboring L. johnsonii UGD (LbjUGD) gene This study
pRSFDuet_ZmUGD pRSFDuet-1 carrying Z. mobilis UGD (ZmUGD) gene This study
pRSFDuet_LbjUGD pRSFDuet-1 carrying LbjUGD gene This study
pUC57_ChUGD pMB1 ori, Amp
R; pUC57 carrying Capra hircus UGD
(ChUGD) gene codon-optimized for S. cerevisiae NZYTech
pSP-GM1 pUC ori, AmpR, 2 µ ori, URA3 PTEF1 PPGK1 Addgene #64739 [28]
p426GPD pUC ori, AmpR, 2 µ ori, URA3 PGPD ATCC 87361
pSP-GM1_ZmUGD pSP-GM1 carrying ZmUGD gene This study
p426GPD_ZmUGD p426GPD carrying ZmUGD gene This study
pSP-GM1_LbjUGD pSP-GM1 carrying LbjUGD gene This study
p426GPD_LbjUGD p426GPD carrying LbjUGD gene This study
pSP-GM1_ChUGD pSP-GM1 carrying ChUGD gene This study
p426GPD_ChUGD p426GPD carrying ChUGD gene This study
2.3. Gene Sources and Cloning Strategy
Table S1 compiles the primers used for gene cloning. UGD genes from Z. mobilis and L.
johnsonii (GenBank accession numbers CP003704.1:c550193-548880 and EF138834.1:15898-
17145, respectively) were amplified from gDNA. Phusion High Fidelity DNA Polymerase
(Thermo Fisher Scientific, Wilmington, United States) was used for all gene amplifications
unless otherwise stated. Amplification of the ZmUGD gene from the Z. mobilis genome
was achieved directly through colony Polymerase Chain Reaction (PCR) using the primers
Zm_Fw and Zm_Rv. The gDNA from the Gram-positive L. johnsonii was extracted from
a 2 mL culture using Wizard® Genomic DNA Purification Kit (Promega, Madison, WI,
USA) according to the manufacturer instructions with slight modifications as follows: the
pellet was treated only with 10 mg/mL of lysozyme prior nuclei lysis; in the end of the
procedure, the DNA was rehydrated with 50 µL of DNA Rehydration Buffer and stored at
4 ◦C. This DNA was used as template for LbjUGD gene amplification with primers Lbj_Fw
and Lbj_Rv. Since the amplification yield was low, the cleaned PCR product was further
A-tailored to be cloned in Promega’s pGEM®-T Easy Vector and the final construction was
used as amplification template. A-tailored product was achieved by adding 5 units of
Dream Taq DNA Polymerase (Thermo Scientific) to the PCR product and 0.2 mM dNTPs
in a final volume of 10 µL and incubating the mixture at 70 ◦C for 30 min. Then, 1 µL
of this reaction was added to a ligation reaction with Promega’s pGEM®-T Easy Vector
according to the kit instructions originating pGEM_LbjUGD. UGD gene from C. hircus
(GenBank accession number XM_018049379.1) was codon-optimized for S. cerevisiae and
synthesized by NZYTech (Table S2). Afterwards, it was amplified from pUC57_ChUGD
using the Ch_Fw and Ch_Rv primers. After amplification, ZmUGD, LbjUGD, and ChUGD
genes were cloned in p426GPD and pSP-GM1. To clone ZmUGD and LbjUGD genes in
pRSFDuet-1, the genes were amplified from p426GPD_ZmUGD and pGEM_LbjUGD using
the Zm_prsf_FW/Zm_prsf_Rv and Lbj_prsf_Fw/Lbj_prsf_Rv primer pairs, respectively.
All genes were cloned in frame with a N-terminal 6× Histidine tag originally present
in pRSFDuet-1 or in the primers used to clone the genes in pSP-GM1 and p426GPD.
Plasmid DNA was extracted using NucleoSpin® Plasmid Miniprep Kit (Macherey-
Nagel, Düren, Germany). Amplified DNA fragments were purified from agarose using
NucleoSpin® Gel and PCR Clean-up Kit (Macherey-Nagel). Plasmid DNA and PCR prod-
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ucts were quantified using a NanoDrop instrument (ND-1000, Thermo Fisher Scientific)
and were digested with the proper restriction endonucleases (Thermo Fisher Scientific) for
1 h at 37 ◦C and purified using NucleoSpin® Gel and PCR Clean-up Kit. Ligations were
performed for 1 h at room temperature using a T4 DNA ligase (Thermo Fisher Scientific).
The constructions were transformed by heat shock into E. coli NZY5α competent cells
(NZYTech). Super optimal broth with catabolite repression (SOC; NZYTech) was used for
transformants recovery. In the case of pGEM_LbjUGD construction, positive transformants
were selected using the blue-white screening method. White colonies were picked from
lysogeny broth (LB) (10 g/L tryptone, 5 g/L yeast extract, 10 g/L NaCl; NZYTech) agar
plates (20 g/L agar, JMGS, Odivelas, Portugal) containing ampicillin (0.1 mg/mL, NZYTech),
5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-Gal, 0.1 mg/mL; NZYTech) and iso-
propyl β-D-1-thiogalactopyranoside (IPTG, 0.5 mM; NZYTech). All plasmids herein con-
structed were verified by colony PCR using Dream Taq polymerase and digestion and their
sequences were further confirmed by sequencing (GATC Biotech, Konstanz, Germany).
After sequence confirmation, E. coli BL21 (DE3) competent cells (NZYTech) were trans-
formed with the constructed plasmids pRSFDuet_ZmUGD, pRSFDuet_LbjUGD and empty
pRSFDuet-1 (used as negative control). Transformations of S. cerevisiae were performed by
lithium acetate/single-stranded carrier DNA/polyethylene glycol method [29]. Lithium
acetate, salmon sperm DNA and polyethylene glycol (PEG-3350) were obtained from
Sigma-Aldrich. Selection of transformants was performed in selective minimal medium
Yeast Nitrogen Base (YNB) with ammonium sulfate without amino acids (Sigma-Aldrich,
St. Louis, MI, USA) with required amino acids in the absence of uracil.
2.4. Culture Conditions
Z. mobilis was grown at 30 ◦C in solid medium with glucose 20 g/L (Acros Organics,
Morris Plains, NJ, USA), yeast extract 5 g/L (Panreac AppliChem, Darmstadt, Germany)
and agar 15 g/L. L. johnsonii was grown in de Man, Rogosa and Sharpe (MRS) medium
(Himedia, Mumbai, India) at 37 ◦C and 200 rpm.
E. coli cultures were incubated at 37 ◦C and 200 rpm in LB, or on LB agar plates.
Ampicillin at a final concentration of 100 µg/mL (NZYTech) or kanamycin at 50 µg/mL
(Fisher Scientific, Springfield, NJ, USA) were supplemented when necessary. For UGD
enzyme expression and consequent UDP-GlcA production, engineered E. coli BL21 (DE3)
were grown by inoculating 1% (v/v) of an overnight pre-culture in 50 mL LB medium
supplemented with kanamycin in 250 mL Erlenmeyer flasks (initial optical density at
600 nm (OD600nm) = 0.1), which were then shaken at 37 ◦C and 200 rpm. E. coli transformed
with the empty vector, pRSFDuet-1, was also grown and used as negative control. When
an OD600nm of 0.6 was reached, IPTG was added at a final concentration of 1 mM. Cells
were then grown at 30 ◦C and 200 rpm for additional 3 h. The absorbance was measured in
a 96-well plate spectrophotometric reader Synergy HT (BioTek, Winooski, VT, USA). Dry
weight of cells was determined through a calibration curve with OD600 nm and expressed
as g/L.
Wild-type S. cerevisiae growth was performed at 30 ◦C, 200 rpm, in Yeast Extract Pep-
tone Dextrose (YPD, 20 g/L bacteriological peptone (HiMedia), 10 g/L yeast extract, 20 g/L
glucose) or in plates with same composition supplemented with agar. After transformation,
cells were grown in YNB plates supplemented with 20 g/L glucose and the required amino
acids depending on the strain (tryptophan, histidine, methionine (Panreac AppliChem)
and leucine (Fisher Scientific) and, in the case of wild-type strains, the pyrimidine uracil
(Sigma)), at final concentrations of 100 mg/L. A single colony was picked from the plate
and grown 24 h in 8 mL YNB for pre-culture. Afterwards, 50 mL of the selective mini-
mal medium YNB supplemented with the required amino acids in 250 mL flasks were
inoculated to an initial OD600 nm of 0.1. Cells were grown at 30 ◦C and 200 rpm for 24–30 h.
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2.5. Preparation of E. coli and S. cerevisiae Protein Extracts
In the end of the fermentation, the final culture of E. coli cells (~50 mL) was centrifuged
(5000× g 15 min) and the pellet resuspended in 10 mL of Tris–HCl buffer (10 mM, pH 7.8).
Cells were then lysed by sonication with a microtip probe linked to Vibra-cell processor
(Sonics, Newtown, CT, USA). Keeping the solution on ice during the procedure, short
pulses of 3 s ON and 9 s OFF at 30% amplitude were performed until 5 min of active
sonication was reached. The resulting lysate was centrifuged (12,000× g 15 min). The
soluble fraction was collected and filtered with 0.2 µm NY filter and the insoluble phase
was saved separately after resuspending the pellet in 1 mL of 10 mM Tris–HCl buffer.
The filtered soluble samples were analyzed to quantify in vivo UDP-GlcA production
through ultra-high-performance liquid chromatography (UHPLC) and were further used
to perform in vitro reactions.
Cells from S. cerevisiae grown cultures (~50 mL) were harvested by centrifugation
(5000× g 15 min). For each 0.1 g of wet cells, 0.2 g of glass beads (425–600 µm, Sigma-
Aldrich) were added to the cells pellet, as well as 2 mL of Tris–HCl (10 mM, pH 7.8) and
1× protease inhibitor cocktail (NZYTech). FastPrep-24 (MP Biomedicals, Salon, USA) was
then used during 5 cycles of 1 min at 6–6.5 m/s interspersed with 1 min cooling on ice.
Lysed samples were centrifuged (16,000× g 15 min) and the supernatant was filtered with
0.2 µm filter. Soluble and insoluble fractions were kept separately. The soluble fraction
samples were analyzed using UHPLC to quantify in vivo UDP-GlcA production and were
used for in vitro reactions.
Protein concentration in the soluble and insoluble fractions was measured using Pierce™
Coomassie (Bradford) Protein Assay Kit according to the manufacturers’ instructions.
The UGD expression of E. coli and S. cerevisiae was evaluated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS–PAGE) [30] (4% stacking gel and 12%
running gel). Samples were mixed with 2× Laemmli Sample Buffer (65.8 mM Tris–HCl
pH 6.8, 2.1% SDS, 26.3% glycerol, 0.01% bromophenol blue, from Fisher Scientific, JMGS,
and Sigma-Aldrich, respectively) with β-mercaptoethanol (AppliChem) and were dena-
tured at 95 ◦C for 5 min. The protein marker used was Color Protein Standard—Broad
Range (NEB, #77125) or NZYColour Protein Marker II (NZYTech). After electrophoresis,
the gel was stained using Coomassie Blue R-250 (AppliChem) for 15 min and de-stained
using distilled water.
2.6. Purification of UGD
Purification of engineered 6× His-tagged UGD from E. coli cell extracts was performed
through affinity chromatography using nickel NTA agarose resin (ABT, Doral, FL, USA)
in 2 mL Pierce™ centrifuge columns (Thermo Scientific) according to ABT’s instructions.
The first elution was performed with 250 mM imidazole (Merck, Kenilworth, NJ, USA)
followed by a second and third elution with 500 mM imidazole. Purified protein was
quantified again with the Bradford Protein Assay Kit and analyzed by SDS–PAGE.
2.7. UGD In Vitro Assays
UGD enzymatic activity was evaluated through in vitro reactions using the different
cell extracts as enzyme source. The in vitro reaction was set by mixing 150 µL of reaction
mixture with 50 µL of cell extracts from E. coli or S. cerevisiae up to a final concentration of
0.25 g/L protein. The reaction mixture was composed by 2.5 mM UDP-Glc (Carbosynth,
Compton, Berkshire, UK), 0.5 mM nicotinamide adenine dinucleotide (NAD+) (Panreac
AppliChem), 1× protease inhibitor and 50 mM Tris–HCl pH 8.6, final concentrations
in the 200 µL total volume. Immediately after adding the reaction mixture to the cell
extract, the microplate was incubated at 30 ◦C for 60 min during which NADH (reduced
form of NAD+) formation was monitored in a microplate reader. A calibration curve was
performed measuring the absorbance at 340 nm of different NADH (Panreac AppliChem)
concentrations (0–750 µM) in a UV-transparent 96-well polystyrene microplate (Sigma-
Aldrich). To evaluate the optimal pH of recombinant UGDs, cell extracts from UGD-
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producing recombinants were incubated in reaction solutions with different pHs (from
3.5 to 9.1) for 1 h at 30 ◦C. To evaluate the optimal temperature, cell extracts were reacted
at different temperatures (from 15 to 40 ◦C) with a pre-heated reaction mixture of pH 8.0
during 1 h. To determine the kinetic parameters of the UGD enzymes, the cell extract at a
final protein concentration of 0.5 g/L was incubated with a pre-heated reaction mixture
(0.5 mM NAD+, 1× protease inhibitor and 50 mM Tris–HCl pH 8.0, at 30 ◦C) with variable
concentrations of UDP-Glc (1–5 mM). Samples were taken at several timepoints during
the incubation (0–15 min). The kinetic parameters Km and Vmax were calculated by fitting
the curve through nonlinear regression to the Michaelis-Menten model using GraphPad
Prism 8.
2.8. Analysis and Quantification of UDP-Sugars
UHPLC analysis was performed to quantify UDP-sugars in bacteria and yeasts’ cell
extracts (in vivo production) or reacted supernatants from in vitro assays. Analysis was
performed using the Shimadzu Nexera-X2 system (Shimadzu Corporation, Kyoto, Japan)
(CBM-20A system controller, LC-30AD pump unit, DGU-20A 5R degasser unit, SPD-M20A
detector unit, SIL-30AC autosampler unit, CTO-20AC column oven) and the column
Luna® Omega 3 µm Polar C18 (150 mm × 4.6 mm, Phenomenex, Torrance, CA, USA).
The column was equilibrated at 25 ◦C in 20 mM tetraethylammonium acetate (pH 6.0)
during 8 min followed by a 22 min gradient from 0 to 5% of acetonitrile. The injection
volume was 5 µL and the working flow rate was 0.5 mL/min. UDP-sugars were detected
at UV260nm absorbance. Retention times of UDP-Glc and UDP-GlcA were 23.8 min and
27.9 min, respectively.
Calibration curves based on UDP-Glc and UDP-GlcA standards (Carbosynth), in
concentrations ranging from 50 to 2000 µM, were performed to quantify UDP-sugars in
the samples.
2.9. Statistical Analysis
GraphPad Prism was used for all statistical analysis and the statistical significance of
the differences between results was based on 2-way ANOVA with multiple comparisons
(Tukey’s or Durnett’s multiple comparisons test).
3. Results
3.1. Sequences and Phylogenetic Analysis
Despite the wide range of biological sources known to express UGD, there are few
studies exploring their cloning or biochemical, structural, and functional characterization.
UniProt entries for this enzyme include 45,705 unreviewed and only 44 reviewed sequences
(data retrieved on 4 October 2021). The enzymes used in this study, ZmUGD, LbjUGD
and ChUGD, are part of the unreviewed group. None of them has been expressed in
heterologous hosts or studied for biotechnological applications. Expressing these UGD
representatives in both prokaryotic and eukaryotic hosts can give new insights e.g., into the
gene selection for biotechnological production of GAGs. Moreover, the selection of ChUGD
as a eukaryotic representative enzyme was based on the fact that the highest reported
specific activity of UGD was obtained using an isolated UGD from caprine liver [31].
UGD belongs to the UDP-glucose/guanosine diphosphate (GDP)-mannose 6- dehy-
drogenase (UGD/GMD) superfamily. These enzymes have a wide range of functions,
often involved in the biosynthesis of polysaccharides and are frequently part of operons
dedicated to that purpose. The sequences of the three enzymes herein studied were aligned
(Figure S1) and their identity was calculated. Percent identity matrix showed that LbjUGD
shares 25% identity with ChUGD and 30% identity with ZmUGD, while ChUGD and
ZmUGD exhibit 37% identify. Afterwards, ZmUGD sequence was screened against the
proteins in the SwissProt database using BLASTp which demonstrated that this enzyme
shares high levels of identity with other enzymes in the UGD/GMD superfamily. The
sequences of the proteins identified as similar to ZmUGD, putative UGDs used in this study
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and UGDs from well-known GAG producers were analyzed through multiple sequence
alignment. The resulting 63 representative amino acid sequences included 29 bacterial
UGD, 1 archaeal UGD, 19 eukaryotic UGD, 5 GMD, 7 UAMAD, 1 UAGAD, and 1 NA-
GAAD. The multiple sequence analysis allowed to identify highly conserved amino acids in
UGD/GMD superfamily and specifically within UGDs (highlighted residues in Figure S1).
Although the amino acid sequences can be very variable within species, all the sec-
ondary structural features were found to be conserved across the UGD/GMD superfamily
sequences, with the largest sequence diversity occurring close to the C-terminus. The
three UGD enzymes cloned in this work presented, as predicted, the described conserved
domains, namely the NAD(+)-binding domain, the central domain, and UDP-sugar bind-
ing domain for the N-terminal, central, and C-terminal regions, respectively (Figure S1).
Regarding the specific active site of UGD, the multiple sequences alignment confirmed
that all sequences of the enzymes evaluated have the conserved residues required for
UGD activity.
Afterwards, the sequences of each of the three studied enzymes were compared with
NCBI sequences using BLASTp. These BLASTp results are described in Table S3. The
BLASTp analysis showed that ZmUGD is significantly similar to the UGD from Sinorhi-
zobium meliloti, followed by the UGDs from Bacillus subtilis subsp. subtilis (YwqF and
TuaD), and UGD from Pseudomonas aeruginosa. Interestingly, these UGDs are from known
polysaccharide producers. Although Z. mobilis itself is a recognized levan producer [32],
S. melitoti is known to produce succinoglycan [33], B. subtilis is also able to synthesize levan,
teichuronic acid and other exopolymeric substances [34,35], and P. aeruginosa produces
alginate [36]. Remarkably, ZmUGD exhibited a higher identity with archaeal UGD from
Haloferax volcanii, eukaryotic UGDs (such as from Drosophila melanogaster, Homo sapiens,
Pongo abelii, Bos taurus and Mus musculus), and even with GMDs, than with other prokary-
otic UGDs such as the heparosan producer E. coli K5. The probiotic L. johnsonii produces
the polysaccharide inulin [37,38], and its UGD showed the highest identity with UGD from
E. coli O111:H−. This strain, as well as the ones with the following greater identity are also
known producers of capsular polysaccharides, including GAGs, namely E. coli O8:K40,
E. coli CFT073/O6:K2:H1, E. coli O157:H7, E. coli K-12, Salmonella enterica and Streptococcus
pyogenes [39–42]. Expectably, ChUGD was highly identical to UGDs from other mammals
(identity from 99.8 to 96% with UGDs from B. taurus, H. sapiens, P. abelli, M. muscullus
and R. novergicus). The following enzymes with similar sequences are UGDs from plants
(59.8 to 61.8% identity with Glycine max, Arabidopsis thaliana and Oryza sativa) followed by
the group of enzymes most similar to ZmUGD.
Finally, a phylogenetic tree was built to show the evolutionary distances between the
63 aligned amino acid sequences (Figure 2). Five main groups of enzymes emerged, namely
eukaryotic UGD, prokaryotic UGD—Group I, prokaryotic UGD—Group II, prokaryotic
GMD and other prokaryotic members of UGD/GMD superfamily. The enzymes used in
this study, indicated in Figure 2 with black arrows, are representative of three different
phylogenetic groups of UGDs. LbjUGD belongs to the group II prokaryotic UGDs, ZmUGD
belongs to group I prokaryotic UGDs, while ChUGD belongs to eukaryotic UGDs group.
Granja et al. [43] previously reported the divergence between the two groups of prokaryotic
UGDs. Enzymes belonging to the so-called group I are more related to eukaryotic UGDs
than to the group II prokaryotic UGDs. This analysis gives insights on which enzymes
exhibit functional similarities, demonstrating that LbjUGD is the most similar to microbial
GAG producers, ZmUGD is included in groups of other types of polysaccharides producing
organisms, while ChUGD is included in the animal GAGs producers.
Life 2021, 11, 1201 9 of 21




other mammals (identity from 99.8 to 96% with UGDs from B. taurus, H. sapiens, P. abelli, 
M. muscullus and R. novergicus). The following enzymes with similar sequences are UGDs 
from plants (59.8 to 61.8% identity with Glycine max, Arabidopsis thaliana and Oryza sativa) 
followed by the group of enzymes most similar to ZmUGD. 
Finally, a phylogenetic tree was built to show the evolutionary distances between the 
63 aligned amino acid sequences (Figure 2). Five main groups of enzymes emerged, 
namely eukaryotic UGD, prokaryotic UGD—Group I, prokaryotic UGD—Group II, pro-
karyotic GMD and other prokaryotic members of UGD/GMD superfamily. The enzymes 
used in this study, indicated in Figure 2 with black arrows, are representative of three 
different phylogenetic groups of UGDs. LbjUGD belongs to the group II prokaryotic 
UGDs, ZmUGD belongs to group I prokaryotic UGDs, while ChUGD belongs to eukary-
otic UGDs group. Granja et al. [43] previously reported the divergence between the two 
groups of prokaryotic UGDs. Enzymes belonging to the so-called group I are more related 
to eukaryotic UGDs than to the group II prokaryotic UGDs. This analysis gives insights 
on which enzymes exhibit functional similarities, demonstrating that LbjUGD is the most 
similar to microbial GAG producers, ZmUGD is included in groups of other types of pol-
ysaccharides producing organisms, while ChUGD is included in the animal GAGs pro-
ducers. 
. 
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Figure 2. Evolutionary relationship between 63 uridine diphosphate (UDP)-glucose 6-dehydrogenase (UGD)-
glucose/guanosine diphosphate (GDP)-mannose 6-dehydrogenase (GMD) superfamily members. The resulting optimal
tree has the sum of branch length = 12.04551231. The tree is drawn to scale, with branch lengths corresponding to the
evolutionary distances used to infer the phylogenetic tree. The dataset comprised a total of 991 sites. Enzymes are labelled by
the two first letters of the genus followed by two letters of species name. The three UGD expressed in this study are indicated
with a black arrow (Lajo, Lactobacillus johnsonii; Cahi, Capra hircus; and Zymo, Zymomonas mobilis). Abbreviation of the
protein is also shown after species name when not UGD, or when multiple UGD isoforms exist within same species. Protein
abbreviations: gmd, GDP-mannose 6-dehydrogenase; uamad, UDP-N-acetyl-D-mannosamine dehydrogenase; uagad,
UDP-N-acetylglucosamine 6-dehydrogenase; and nagaad, nucleotide diphosphate (NDP)-N-acetyl-D-galactosaminuronic
acid dehydrogenase.
3.2. E. coli as UGD Expression Host
Since there are several reports on eukaryotic UGDs expressed in E. coli that were not
active [44–47], only the two prokaryotic genes were here expressed in E. coli BL21 (DE3).
This host was evaluated for the expression of ZmUGD and LbjUGD by SDS–PAGE (Figure 3).
Based on their amino acid sequence, the expected sizes for the recombinant 6× His ZmUGD
and 6× His LbjUGD were calculated to be 49.2 kDa and 48.0 kDa, respectively.
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Figure 3. SDS–PAGE gel showing 6-His-tagged uridine diphosphate-glucose dehydrogenases (UGDs)
expression in Escherichia coli BL21. Lane L on the left corresponds to the ladder Color Prestained
Protein Standard, Broad Range (11–245 kDa). Samples loaded were: (1) soluble cell extract of E. coli
pRSFDuet-1 (15 µg), (2) soluble cell extract from E. coli pRSFDuet_ZmUGD (15 µg), (3) 1st eluted
fraction from ZmUGD purification (5 µg), (4) soluble cell extract from E. coli pRSFDuet_LbjUGD
(15 µg), (5) 1st eluted fraction from LbjUGD purification (5 µg), (6,7) 2nd eluted fractions from
ZmUGD and LbjUGD purification, respectively (5 µg).
As it can be observed, ZmUGD and LbjUGD were efficiently overexpressed in E. coli
and exhibited the correct size. After UGD purification, as expected, the fraction from the
2nd elution showed a cleaner band.
The UDP-GlcA production in vivo by the engineered E. coli was quantified by UH-
PLC. Figure 4 shows the UDP-Glc and UDP-GlcA quantification in bacterial cell extracts,
normalized by the dry cell weight obtained at the end of the fermentation.
UDP-Glc is naturally produced from glucose in E. coli BL21. The UDP-Glc in this
strain can be used for the biosynthesis of trehalose, lipid A-core, cellulose, or for galac-
tose degradation via the Leloir pathway. Although there is still no wet lab confirmation,
the gene prediction computational methods by protein homology suggest that this strain
contains a UGD gene (NCBI sequences NC_012892 region: 1994244-1995410; NC_012971
region: 1994250-1995416), which justifies the presence of small amounts of UDP-GlcA in
the negative controls. Additionally, it is known that E. coli BL21 has a polymyxin resis-
tance pathway [48] that requires the use of UDP-GlcA. Additionally, there is evidence
that UDP-Glc regulates the activity of enzymes in E. coli. UDP-Glc enhances adenosine
diphosphate-sugar pyrophosphatase activity, which can lead to reduced glycogen produc-
tion by the cell [49].
When recombinant UGDs were expressed in E. coli BL21 cells, UDP-GlcA formation
became evidently higher in their cell extracts compared to the one carrying the empty vector.
The highest UDP-GlcA in vivo production at the end of fermentation was achieved by E. coli
expressing ZmUGD, 28.4 µM (or 23.6 µmol·g−1 cell dry weight, CDW), while the E. coli
expressing LbjUGD produced 14.9 µM (or 12.7 µmol·g−1 CDW). Interestingly, the UDP-
GlcA production did not result in a reduction of the UDP-Glc pool in the engineered E. coli.
In the work of Cimini et al. [50] the UDP-sugars levels were accessed in wild-type and in
an E. coli K4 engineered strain. UDP-Glc varied approximately from 0.1 to 0.4 µmol·g−1
CDW while UDP-GlcA varied from 0.1 to 1.2 µmol·g−1 CDW, depending on the strain and
on the time of fermentation. Restaino et al. [8] reported that UDP-sugars concentrations
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during microbial fermentations of the pathogenic E. coli K4 or E. coli K5 in different media
varied between 0.25 and 11.0 µM·g−1 CDW (from 0.2 to 12.0 µM), depending on the strain,
type of precursor, growth phase, and culture conditions. Specifically, using E. coli K4
grown in a glycerol-based medium, UDP-Glc concentrations varied from 8.1 to less than
0.5 µM·g−1 CDW and UDP-GlcA from 0.25 to approximately 0.48 µM·g−1 CDW. When
using E. coli K5 in the same medium, UDP-Glc and UDP-GlcA concentrations varied from
around 11 to 1 µM·g−1 CDW and from almost undetectable to approximately 1.5 µM·g−1
CDW, respectively. The authors showed that the UDP-precursors availability considerably
influenced the total chondroitin or heparosan produced. Fermentation using recombinant
strains of S. zooepidemicus [51] resulted in the same range of UDP-sugar precursors in
the exponential phase. UDP-Glc varied from approximately 1.1 to 3.9 µmol·g−1 CDW
and UDP-GlcA varied from almost 0 to 17.2 µmol·g−1 CDW, according to the strain. It is
important to notice that in the referred studies there is not much accumulation of UDP-GlcA
as in the current work because it is being redirected for GAGs production. Nevertheless,
the results from the present work show that the E. coli BL21 was able to produce UDP-GlcA
in the same range as the reported for GAGs-producing pathogenic strains.
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Figure 4. In vivo uridine diphosphate-glucose (UDP-Glc) and UDP-glucuronic acid (UDP-GlcA)
production by Escherichia coli BL21 harboring pRSFDuet-1, pRSFDuet_ZmUGD or pRSFDuet_LbjUGD,
the last two expressing an extra copy of UDP-Glc dehydrogenase (UGD) from Zymomonas mobilis
(ZmUGD) and Lactobacillus johnsonii (LbjUGD), respectively. Results are normalized by the cultures’
dry weight of cells at the end of the fermentation. The fermentations were performed in triplicate.
Four asterisks (****) identify statistically significant differences with adjusted p values < 0.0001.
After evaluating UDP-GlcA productions in vivo, cell extracts were used to perform
in vitro reactions that were analyzed by UHPLC (Figure 5). Cell extracts were used because
after His-Tag purification, recombinant UGDs showed no activity in vitro (data not shown).
Differently from the in vivo results, in the in vitro assay using cell extracts, the enzyme
LbjUGD resulted in t highest UDP-GlcA production, despite not being sta istically
different than ZmUGD. The variations from in vitro and in vivo reactions may be explained
by the different pH and temperature conditions at which the assays are conducted. After 1 h
of reaction, the cell extract containing LbjUGD led to a 229 µM production in vitro, while the
one containing ZmUGD led to a 95 µM production under the same conditions. Differences
on substrate and product concentrations betwee reactions of LbjUGD recombinant enzyme
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and negative control were statistically significant at a 95% confidence level. The initial
UDP-Glc concentration was 2.5 mM and from Figure 5 it is possible to conclude that
more UDP-Glc was consumed than the one required to produce the detected amounts of
UDP-GlcA. This was observed also in the negative control which again shows the ability of
the enzymes from E. coli BL21 to use UDP-Glc as substrate for competitive reactions, such
as for the biosynthesis of trehalose or lipid A-core, and the ability of endogenous UGD
to convert UDP-Glc to UDP-GlcA that can be afterwards metabolized in the polymyxin
pathway or for colanic acid biosynthesis.
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The NADH production was also evaluated through the monitoring of the absorbance
at 340 nm (Figure S2) during the in vitro reactions. Absorbance increases with the NADH
production. For each mol of UDP-Glc that is converted into UDP-GlcA by UGD, 2 mol
of NADH are p od ced. However, NADH is not a suitable indicator of UGD e zymatic
activity in crude cell extracts since it can also be produced by other enzymes. Nevertheless,
the highest NADH productions were obtained in the reactions using cell extracts from
engineered E. coli expressing LbjUGD, as observed by the quantification of UDP-GlcA
by UHPLC.
S. cerevisiae was further used as expression host for UGD in an attempt to achieve
higher e zymatic activities a d consequently highe UDP-GlcA titers.
3.3. Three Novel UGDs Expressed in Yeasts
In this work, the budding yeast was evaluated as an expression system for UGD
enzymes since the use of eukaryotic hosts could improve the solubility and activity of
the xpressed enzymes. In particular, eukaryotic enzymes that are n t easily expressed in
E. coli can become viable alternatives for the construction of biosynthetic pathways.
Besides the same two prokaryotic genes previously expressed in E. coli, one eukaryotic
UGD, codon-optimized for S. cerevisiae, was evaluated for UDP-GlcA production. The expres-
sion of the UGDs, fused to a His-Tag, was evaluated through SDS–PAGE (Figure S3). The
transformed S. cerevisiae strai s did not sh w an increased UGD expression compared to
the other proteins in their cell extract and to the controls. The expected sizes of ChUGD,
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ZmUGD, and LbjUGD enzymes were 55.9 kDa, 48.2 kDa and 47.4 kDa, respectively. The
purification of the his-tagged proteins was performed but the proteins could not be ob-
served in the gels and the amounts produced were not enough to further use in in vitro
assays. Although the constitutive promoters used (phosphoglycerate kinase, PGK1, or
glyceraldehyde-3-phosphate dehydrogenase, GPD, promoters) are widely applied for high
constitutively expression of recombinant proteins in yeasts [52–55], the expression is not
comparable to the prokaryotic E. coli system where the exceptionally strong T7 promoter
and a high copy number plasmid were used.
The cell extracts were analyzed through UHPLC and UDP-GlcA, although in very
small amounts, was detected for all engineered S. cerevisiae strains. Contrarily to E. coli,
S. cerevisiae does not harbor the UGD gene in its genome. Therefore, UDP-GlcA was not
detected in cell extracts of wild-type yeasts. The in vivo production of UDP-GlcA by
S. cerevisiae expressing recombinant ChUGD, LbjUGD and ZmUGD is shown in Figure 6.





Figure 6. In vivo uridine diphosphate (UDP)-sugars production by Saccharomyces cerevisiae CEN.PK2-1C and BY4741 wild 
types (wt.) and engineered strains expressing UDP-glucose dehydrogenase (UGD) from Capra hircus (ChUGD), Zymomonas 
mobilis (ZmUGD) and Lactobacillus johnsonii (LbjUGD). Standard deviations are relative to at least three different trans-
formed colonies tested. Differences in the UDP-glucuronic acid (UDP-GlcA) concentrations between the mutants and the 
correspondent wild-type are indicated, with statistical significance represented with two asterisks (**) for adjusted P val-
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It has been reported that in S. cerevisiae, UDP-Glc is a naturally abundant substrate in 
the cytoplasm, required for the synthesis of β-glucan polysaccharides [56], but also for 
trehalose and glycogen biosynthesis. The UDP-Glc concentration herein obtained ranged 
from 1.3 to 9.9 µM (0.7 to 8.4 µmol·g−1 CDW), depending on the strain and plasmid used. 
In general, within each strain, differences between UDP-Glc concentration of all the dif-
ferent combinations were not statistically significant. In terms of UDP-GlcA production, 
all mutants showed increased UDP-GlcA production, due to UGD overexpression, as 
compared to the negative controls. However, differences were not statistically significa-
tive in S. cerevisiae BY4741 engineered strains compared to the wild-type strain. It is im-
portant to mention that as episomal plasmids were used as expression vectors, different 
yeast transformed colonies can have huge differences in terms of plasmid copy number 
and, consequently, in product concentration. Hence, future integration in the genome, as 
single or multiple gene copies, could result in more reproducible effects [57]. 
S. cerevisiae CEN.PK2-1C harboring pSP-GM_ChUGD, p426GPD_ChUGD, pSP-
GM_ZmUGD and p426GPD_ZmUGD showed the highest statistically significant produc-
tion compared to the wild-type, producing on average 14.6, 10.5, 17.9 and 15.9 µM, re-
spectively (corresponding to 13.1, 9.7, 13.5 and 13.6 µmol·g−1 CDW). As it can be observed, 
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wild types (wt.) and engineered strains expressing UDP-glucose dehydrogenase (UGD) from Capra hircus (ChUGD),
Zymomonas mobilis (ZmUGD) and Lactobacillus johnsonii (LbjUGD). Standard deviations are relative to at least three different
transformed colonies tested. Differences in the UDP-glucuronic acid (UDP-GlcA) concentrations between the mutants and
the correspondent wild-type are indicated, with statistical significance represented ith two asterisks (**) for adjusted
p values < 0.01 and with fou asterisks (****) for p values < 0.0001. Statistically no -significativ differenc s are not shown
for simplification.
It has been reported that in S. cerevisiae, UDP-Glc is a naturally abundant substrate
in the cytoplasm, required for the synthesis of β-glucan polysaccharides [56], but also for
trehalose and glycogen biosynthesis. The UDP-Glc concentration herein obtained ranged
from 1.3 to 9.9 µM (0.7 to 8.4 µmol·g−1 CDW), depending on the strain and plasmid
used. In general, within each strain, differences between UDP-Glc concentration of all the
different combinations were not statistically significant. In terms of UDP-GlcA production,
all mutants showed increased UDP-GlcA production, due to UGD overexpression, as
compared to the negative controls. However, differences were not statistically significative
in S. cerevisiae BY4741 engineered strains compared to the wild-type strain. It is important
to mention that as episomal plasmids were used as expression vectors, different yeast
transformed colonies can have huge differences in terms of plasmid copy number and,
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consequently, in product concentration. Hence, future integration in the genome, as single
or multiple gene copies, could result in more reproducible effects [57].
S. cerevisiae CEN.PK2-1C harboring pSP-GM_ChUGD, p426GPD_ChUGD, pSP-GM_ZmUGD
and p426GPD_ZmUGD showed the highest statistically significant production compared to
the wild-type, producing on average 14.6, 10.5, 17.9 and 15.9 µM, respectively (correspond-
ing to 13.1, 9.7, 13.5 and 13.6 µmol·g−1 CDW). As it can be observed, the engineered strains
expressing the eukaryotic enzyme ChUGD and the ones expressing the prokaryotic enzyme
ZmUGD exhibited greater UDP-GlcA amounts, while the systems expressing LbjUGD
generated lower UDP-GlcA levels in vivo. This observation suggests that UGD enzymes
from the eukaryotic and group I prokaryotic phylogenetic groups (Figure 2) have improved
in vivo activity compared to group II prokaryotic UGDs. The work of Oka & Jigami [56]
was the only one that so far reported the use of S. cerevisiae, specifically the strain W303a,
to express UGD. The expression of one of the UGD isoforms from A. thaliana, allowed to
obtain an in vivo UDP-GlcA production of 5.71 ± 1.06 µmol·g−1 CDW, and the substrate
UDP-Glc was reduced 54% (from 2.21 µmol·g−1 CDW to 1.20 µmol·g−1 CDW) compared
to the wild-type. This decrease in UDP-Glc pool was not observed in the current work.
Nevertheless, the values of UDP-GlcA herein achieved are 2 to 3 times higher (depending
on the strain) than the ones obtained by those authors. In a different work, Zhou et al. [47]
expressed a fungal UGD using a different yeast as host, namely Pichia pastoris. However,
no values of UDP-GlcA production are reported in this study.
The slightly reduced in vivo UDP-GlcA production obtained with S. cerevisiae com-
pared to E. coli might be due to the absence of a UGD homolog gene in S. cerevisiae as it
occurs in bacteria.
Afterwards, the in vitro UDP-GlcA production was evaluated. Figure 7 shows the
UHPLC results obtained from the in vitro reactions using the yeast cell extracts.
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Although the differences in UDP-GlcA concentrations were not statistically signifi-
cant, LbjUGD in yeast cell extracts exhibited the highes UDP-GlcA concentrations in vitro,
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resembling what was observed in the in vitro reactions using E. coli cell extracts. The
higher final UDP-GlcA concentrations obtained were on average: 482 µM using S. cerevisiae
CEN.PK2-1C pSP-GM_LbjUGD; 480 µM using BY4741 p426GPD_LbjUGD; 469 µM using
CEN.PK2-1C p426GPD_LbjUGD; and 439 µM with BY4741 pSP-GM_LbjUGD. The high
standard deviation values are related to the use of cell extracts from different transformed
colonies for the in vitro reactions. As it can be observed, the UDP-GlcA production in vitro
was not significantly affected using different vectors or promoters for UGD expression.
Using plasmids pSP-GM1 and p426GPD, containing PGK1 and GPD promoters, respec-
tively, for UGD expression did not seem to result in statistically significative differences in
UDP-GlcA production in vitro.
The NADH production was also evaluated through the monitoring of the absorbance
at 340 nm (Table S4). The highest NADH productions were obtained in the reactions using
cell extracts from engineered yeasts expressing LbjUGD, which is in agreement with the
obtained results of UDP-GlcA production.
The obtained results for the in vitro reactions using yeast cell extracts resembled the
ones obtained with E. coli cell extracts. The enzyme that generally led to the highest UDP-
GlcA concentration in vitro in engineered yeast, LbjUGD, was not the one that allowed the
highest production of UDP-GlcA in vivo. Again, in vivo and in vitro conditions, such as the
pH, were different which may justify the different relative activities found to the enzymes.
Comparing the prokaryotic and eukaryotic hosts for UGD expression, while the
highest in vivo UDP-GlcA production was achieved with engineered E. coli, the enzymes
expressed in S. cerevisiae exhibited higher UDP-GlcA production in vitro. This suggests
that the conditions used for in vivo UDP-GlcA production in yeasts are probably not
appropriate for optimal UGD activity. For example, the pH of yeast cell extracts at the
end of fermentation was slightly lower (around 6.0) than the pH of cells extracts obtained
after culturing E. coli (around 7.0), and UGDs usually have an optimal activity at basic
pH as further discussed below. Therefore, if an in vivo strategy is envisaged, S. cerevisiae
fermentation needs to be further optimized.
It was demonstrated that ZmUGD was the enzyme that more actively converted
UDP-Glc to UDP-GlcA in vivo in both prokaryotic and eukaryotic hosts. In the yeast,
ChUGD allowed to produce the same UDP-GlcA levels as ZmUGD. However, cell extracts
containing LbjUGD produced the highest UDP-GlcA, in both prokaryotic and eukaryotic
hosts. Contrarily to what might be expected, the activities in vivo and in vitro of ZmUGD
and LbjUGD were very distinct, regardless of the host, despite being both from prokaryotic
sources; being ZmUGD and ChUGD more similar in terms of enzymatic activities as shown
by UDP-GlcA production. This can be related to the fact that ZmUGD sequence is more
similar to ChUGD than to LbjUGD as observed from the phylogenetic analysis (Figure 2).
3.4. Biochemical Characterization of Cloned UGDs
The cell extracts from E. coli and S. cerevisiae were used to determine the optimal pH
and temperature for UGD recombinant enzymes under in vitro conditions. Figure 8 shows
the in vitro relative enzymatic activity between different cell extracts, when varying the
pH (Figure 8A,B) and the temperature (Figure 8C,D), according to the final UDP-GlcA
concentration determined by UHPLC. The S. cerevisiae strain used for UGD expression was
CEN.PK2-1C as it was the strain that previously led to higher productions in vivo and the
results in vitro of both strains were similar. The genes were expressed under control of
the PGK1 promoter as no significant differences among the two promoters tested were
previously observed.
Cell extracts from engineered E. coli were used and the two expressed UGD enzymes,
ZmUGD and LbjUGD, showed slightly different properties (Figure 8A,C). Again, LbjUGD
allowed to produce more UDP-GlcA in vitro than ZmUGD. Regarding the different pH,
higher UDP-GlcA content was obtained at the pH 7.1. The optimal temperature for E. coli
expressed ZmUGD was 30 ◦C while the LbjUGD conserved its maximal activity between
25 ◦C and 35 ◦C. From the UGDs expressed in S. cerevisiae, LbjUGD generally exhibited
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the highest activity in vitro under different pH and temperatures (Figure 8B,D). Its activity
was maximal at the temperature of 35 ◦C and a pH of 8.5. The other UGDs showed lower
activities under all pH tested and exhibited the maximal activity at 35 ◦C.
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to the highest activity of (A) 31.1 × 10−3 U/mL, (B) 9.8 × 10−3 U/mL, (C) 8.4 × 10−3 U/mL and (D) 3.9 × 10−3 U/mL, in all cases 
achieved when the UGD from Lactobacillus johnsonni (LbjUGD) was expressed. One unit of UGD activity was defined as 
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Nevertheless, these results are in accordance with the reported studies on UGD
activities from other organisms. For example, the pH optimum for Cryptococcus laurentii
UGD activity was in the range of 7.3–7.8 [58]; the optimum pH and temperature of soybean
UGD were reported to be 8.7 and 30 ◦C [59]; optimal pH for UGD activity of sugarcane
was 8.4 [60]; UGD from Sphingomonas elodea exhibited optimum pH and temperature of
8.7 and 37 ◦C [43]; the UGD from the fungus Phoma herbarum showed the highest activity
at a pH of 8.6 and at 35 ◦C [47]; P. multocida’s UGD activity was optimal at a pH of 10 and
37 ◦C [7]; and UGDs from Granulibacter bethesdensis and Akkermansia muciniphila showed
optimal activity at 37 ◦C and pH 9.0 [61,62].
Expectably, these results show a general increase in UDP-GlcA concentration com-
pared to the in vitro assays previously performed under non-optimal conditions. In these
experiments, UDP-GlcA concentrations using cell extracts from E. coli expressing LbjUGD
and ZmUGD reached on average 1800 µM and 407 µM, respectively (pH 7.1 and 30 ◦C,
Figure 8A). When using cell extracts from engineered S. cerevisiae strains, the maximum
UDP-GlcA concentration achieved with ChUGD and ZmUGD was 116 µM and 134 µM
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(pH 7.2 and 30 ◦C, Figure 8B), while LbjUGD allowed to obtain 533 µM (pH 8.5 and 30 ◦C,
Figure 8B).
This biochemical characterization of UGDs could explain the differences previously
obtained in in vivo and in vitro UDP-GlcA production using the different expression
systems. It was observed that UGD enzymes produced more UDP-GlcA in vivo using
E. coli than S. cerevisiae. That result could be justified by the acidic environment of yeast
fermentation being far from the optimal pH of UGDs. Additionally, it is demonstrated
that the LbjUGD activity is highly affected by the pH, so in the buffered in vitro reactions
it has shown a much better performance than in vivo where pH is changing with the
fermentation time. Additionally, in E. coli the expression temperature was 30 ◦C which was
optimal for the enzymes expressed in that system (Figure 8C). However, the temperature
of 30 ◦C, used for S. cerevisiae fermentation, was not the optimal for UGDs expressed in
that chassis (Figure 8D).
Moreover, in the case of the in vitro reactions performed, presented in Sections 3.2 and 3.3,
it is important to notice that they were performed at 30 ◦C and at a pH of 8.0 which was
here demonstrated to be close to, but not the optimal conditions for UGDs expressed in
E. coli and in S. cerevisiae, thus suggesting that the UDP-GlcA production could be further
improved. The kinetic parameters (Km and Vmax) (Table 2). were also determined under
these conditions.
Table 2. Kinetic parameters Vmax and Km for each enzyme expressed in this study. ZmUGD: Uridine diphosphate-glucose
dehydrogenase (UGD) from Zymomonas mobilis; LbjUGD: UGD from Lactobacillus johnsonii; ChUGD: UGD from Capra hircus.





ZmUGD 81 2586 3.1 × 10−2
LbjUGD 66 1939 3.4 × 10−2
Saccharomyces cerevisiae
ChUGD 2.2 841 2.6 × 10−3
ZmUGD 3.7 1234 3.0 × 10−3
LbjUGD 1.4 314 4.5 × 10−3
As it can be seen through the Vmax/Km ratio, the enzyme that showed the highest
potential was LbjUGD both in E. coli and S. cerevisiae systems, which agrees with the previ-
ous observed results from in vitro reactions that showed that LbjUGD was able to produce
more UDP-GlcA in the assay conditions. Since the kinetic parameters of characterized UGD
in the literature are generally calculated with purified enzyme, it was expected that the pa-
rameters herein estimated would be significantly different from previous reports. Since the
protein concentration in the cell extracts accounts for much more proteins than UGD, the
reaction maximum velocities of the expressed UGDs were lower and required higher con-
centrations of UDP-Glc to obtain half of the maximum velocity (higher Km). This effect is
obviously more pronounced in the enzymes expressed in yeasts since, as mentioned before,
the expression of enzymes was not as evident as the ones expressed in E. coli, where the
overexpression was easily observed in the SDS-PAGE gels. Examples of reported UGD ki-
netic parameters are: Km of 230 µM and a Vmax of 8.0 × 103 µmol·min−1·gprotein−1 for UGD
from Burkholderia cepacia [63]; Km and Vmax of 110 µM and 9.8 × 109 µmol·min−1·gprotein−1,
respectively, for UGD from P. multocida [7]; an apparent Km of 137.2 µM [64] for a recom-
binant UGD from Bacillus cereus expressed in E. coli; and a Km of 34 µM and a Vmax of
313 µmol·min−1·gprotein−1 for the human UGD recombinantly expressed in E. coli [65].
4. Conclusions
Although UGD is considered a bottleneck step for GAGs biotechnological production,
few alternative UGDs have been characterized and evaluated for such purpose. In addition,
the use of eukaryotic hosts to express enzymes from the GAG production pathway has been
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absent in the literature although they are candidate systems that could possibly address
the low solubility and activity of recombinant enzymes.
Herein, three UGD enzymes (ZmUGD, LbjUGD and ChUGD) were expressed in
S. cerevisiae and two prokaryotic enzymes (ZmUGD and LbjUGD) were expressed in E. coli.
The sequences of the UGDs in this study were compared with other reviewed enzymes
using bioinformatic tools and a phylogenetic analysis was performed, being the three genes
cloned in this study representative of three UGD phylogenetic groups. ZmUGD was found
to be functionally closer to ChUGD than to the other prokaryotic LbjUGD.
The activity of the UGDs was evaluated through quantification of UDP-sugars pro-
duction in vivo in both E. coli and S. cerevisiae cell extracts, with and without expressing the
recombinant UGD. E. coli was found to be a useful system for protein expression since the
recombinant proteins ZmUGD and LbjUGD were clearly overexpressed in a soluble form
and a significant increase in the UDP-GlcA pool in cell extracts of engineered E. coli was
observed as compared to the negative control. However, in vitro, the UDP-GlcA concen-
tration did not increase very significantly. Moreover, the same two prokaryotic enzymes
and one eukaryotic UGD, codon-optimized for S. cerevisiae (ChUGD), were evaluated for
UDP-GlcA production, using two different yeast strains and expression vectors. When
using S. cerevisiae as the heterologous host, the expression of recombinant enzymes was not
demonstrated in SDS–PAGE. However, the quantification by UHPLC demonstrated that all
engineered yeasts produced more UDP-GlcA in vivo than the control strains. The strains
with highest in vivo UDP-GlcA production were S. cerevisiae CEN.PK2-1C expressing
ZmUGD or expressing ChUGD. Although the highest in vivo UDP-GlcA production was
achieved with engineered E. coli, the enzymes expressed by S. cerevisiae exhibited higher
performance in vitro. The cell extracts were further used to determine the optimum pH
and temperature for the UGD recombinant enzymes under in vitro conditions. Generally,
the optimum conditions that maximize the UGD enzymes activity were a pH between
7 and 9 and a temperature between 30 and 35 ◦C. Remarkably, the enzyme that generally
showed highest activity in vitro in both E. coli and yeast mutants, LbjUGD, was not the
one that allowed the highest production of UDP-GlcA in vivo, thus suggesting that the
in vitro and in vivo conditions were sufficiently different leading to different relative activ-
ities. Depending on the strategy intended for GAGs production, i.e., in vivo or enzymatic
production, different enzymes should be used, according to their kinetics, towards higher
product yields.
This work evaluates alternative genes for biotechnological applications, including
GAGs microbial production, recombinant protein production for enzymatic production of
GAGs or to produce expensive UDP-precursors for further chemical and/or enzymatic
production of GAGs. These novel UGD genes showed to efficiently convert UDP-Glc into
UDP-GlcA (up to 74% conversion using LbjUGD in the optimal conditions) and should
be explored for the construction of a complete heterologous pathway for in vivo GAG
production. Additionally, metabolic engineering of host microorganisms for improving
UDP-Glc availability should be considered, either by overexpressing the pathway genes
and regulators and/or by performing the knockout of competitive reactions (essentially
cell wall recycling pathways) to improve intermediate pools and subsequent availability.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/life11111201/s1, Table S1: Primers used in this study, Table S2: Gene sequence of UGD from
Capra hircus, Table S3: Results of BlastP sequences search against UniProtKB/Swiss-Prot database,
Figure S1: Multiple amino acid sequence alignment of the three uridine diphosphate-glucose de-
hydrogenases used in this study, Figure S2: In vitro reduced nicotinamide adenine dinucleotide
(NADH) production over time in engineered Escherichia coli, Figure S3: SDS-PAGE gels from Saccha-
romyces cerevisiae cell extracts, Figure S4: In vitro reduced nicotinamide adenine dinucleotide (NADH)
production over time in engineered S. cerevisiae.
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